Bayer Crop Science | Innovation Ecosystem’s Post

These are the winning teams of the Research To Market Challenge 💥 BatteryBoostAI 💥 micropBoost 💥 Oncovirtuous 💥 Y Information-as-a-Service An expert jury from Science & Startups selected the best business ideas as part of the “Research to Market Challenge”. BatteryBoostAI won in the “Technologies x Resources” category. The team's idea can contribute to the reuse of used batteries. “micropBoost” won in the “Sustainability x Society” competition line. The team convinced the jury with the idea of using the power of plant microbiota to protect crops from pests and to support sustainable food production with the help of these natural bacterial products. In the category “Healthcare x Prevention” won Oncovirtuous. The team's goal is to effectively combat tumors with mRNA. “Y Information-as-a-Service” received the special “Artificial Intelligence” award for the development of an AI platform. For more than 10 years, the Research to Market Challenge has been a platform for innovative ideas from science from the Freie Universität Berlin Humboldt-Universität zu Berlin, Technische Universität Berlin and Charité - University Medicine Berlin Did you miss the challenge? Do you also have an idea that you would like to develop further? Very good! Science & Startups is once again awarding the hashtag#BerlinerStartupScholarship this year and you can apply quickly now – until May 28th (Tuesday). You can find the link with all the information in the comments 👇 #startups #innovationen #r2mc #wettbewerb #gründen #pioneers #berlin #founding #scienceandstartups #science #ideas #challenge #ki #ai #Healthcare #Prevention #Sustainability #Society #Technology #Resources

Lithuanian startup Biomatter recently secured €6.5 million in seed funding to advance its generative AI platform for enzyme design. The funding round was led by Inventure and UVC Partners, with participation from existing investors and industry experts. This significant investment will enable Biomatter to enhance its technology and accelerate the development of novel enzymes for various applications. Biomatter, founded by Donatas Repečka, Laurynas Karpus, Rolandas Meškys, and Vykintas Jauniskis, focuses on creating new proteins and enzymes using AI, aiming to revolutionize industries such as health, sustainable manufacturing, and agriculture. Their technology offers a more efficient approach to enzyme design, overcoming traditional trial-and-error methods and broadening potential applications. Biomatter has already partnered with notable companies like Thermo Fisher Scientific and BASF to produce unique enzymes. With the newly raised funds, Biomatter plans to expand its platform capabilities and meet increasing customer demand. Their goal is to push the boundaries of enzyme design, contributing to advancements in medicine, chemical manufacturing, and food production. This investment marks a significant step forward in the development of AI-driven synthetic biology.

🌟 Bridging the Gap Between Academia and Industry: A Successful Industry Interaction at Dextrose Technologies Pvt Ltd! 🌟 We are thrilled to share the success of our recent Industry Interaction event, where students and professionals came together to explore the latest trends and innovations in biotechnology. This event provided a platform for meaningful dialogue between academia and industry, offering participants valuable insights into real-world applications of their studies. Our experts shared their knowledge on: 🔬 Cutting-edge research and development in biotechnology 🧪 The importance of industry-academia collaboration in driving innovation 💼 Entrepreneurship opportunities in the biotech sector 🎯 Career pathways and skill development for aspiring professionals Our Managing Director, Mr. Aravind Ganessin, delivered inspiring talks on the evolving landscape of biotechnology and the critical role of industry exposure in shaping the next generation of scientists and entrepreneurs. A big thank you to all the students who participated and made this event a resounding success. We are excited to continue fostering strong ties between academia and industry, paving the way for future collaborations and breakthroughs. Stay tuned for more such enriching interactions! #IndustryInteraction #Biotechnology #AcademiaAndIndustry #DextroseTech #Innovation #CareerDevelopment #Entrepreneurship #BiotechIndustry

If you are an entrepreneur in the high end scientific or technology sectors, this case study can be interesting for you. Articulating your value proposition and business growth potential can be a formidable challenge. The complexity of your innovations often requires a unique narrative that resonates with investors and stakeholders. At Divocate, we understand these challenges and excel at transforming intricate scientific concepts into compelling investment stories. One such success story is our collaboration with Bio Designs Analytics. The Challenge: Simplifying the Complex Bio Designs Analytics, a pioneering company in genetic customization and optimization, faced the daunting task of explaining their advanced technologies and immense potential to investors. Despite being led by industry veterans with over a century of combined experience, the team struggled to create an investment narrative that was both comprehensible and captivating. Our Strategic Contribution At Divocate, we took on this challenge headfirst. Our mission was to craft a clear, compelling investment narrative that would highlight Bio Designs Analytics' groundbreaking work and future potential. We helped Bio Designs Analytics articulate their value proposition in a way that resonated with investors on a global scale. Through strategic planning and expert guidance, we ensured that Bio Designs Analytics secured the substantial funding needed to fuel their operations and growth. About Bio Designs Analytics Imagine a world free from hunger, where plants and animals are customized for optimal growth and resilience. Bio Designs Analytics is turning this vision into reality. Their mission is to spearhead the next agricultural revolution by harnessing the power of machine learning to drive genetic customization and optimization. They address global challenges such as food security, climate resilience, pest and disease resistance, and more. Empowering Innovation and Growth Our partnership with Bio Designs Analytics highlights our ability to support high-tech and biotech companies in articulating their value proposition and achieving growth. At Divocate, we are proud to empower innovators by providing strategic insights, expert guidance, and comprehensive planning. Together, we are driving the future of genetic engineering and sustainable agriculture. At Divocate, we are committed to helping businesses navigate their complex landscapes, turning visionary ideas into reality. Our collaboration with Bio Designs Analytics is a testament to our dedication to excellence and innovation in the science and technology sectors. #biotech #investment #Divocate #FundraisingConsulting #TechStartUp #FundraisingStrategy #StartupFunding #TechInvestment #FundraisingExpert #TechnologyConsulting #MENAFundraisng #MENAStartup

For every exciting discovery in research, there’s also a long process of moving these findings into practical application, whether it’s creating a new device that can save on energy, a new test or treatment for a health condition, or a technology that can help reduce or eliminate carbon emissions. Read more in the newest issue of Rice Magazine about how Rice University has become an innovator in how to support innovation. cc: Haotian Wang, Rawand Rasheed, PhD, Ryan DuChanois, Yang Xia, Suman Khatiwada, PhD, Adrian Trömel, Samantha Fleury, Samira Aghlara-Fotovat, Lee French

APPLICATION NOW OPEN for the Plug and Play 2024 Beijing Synthetic Biology Proof-of-Concept Accelerator Batch: Innovate for a Sustainable Future! 🍃Join the Movement for a Greener Tomorrow! 🗓  Now – December, 2024 In partnership with Beijing, Plug and Play China proudly announces the launch of the "Synthetic Biology Proof-of-Concept Accelerator Batch" – a beacon for the future of industry, where innovation meets sustainability. Elevate Your Vision with Pioneering Technologies: This accelerator is a call to synthetic biology innovators worldwide, inviting you to seize the frontier of industrial innovation. With a focus on – food, health, beauty, and agriculture – we aim to revolutionize traditional industries and pioneer new ones. Industry Giants Aligned for Progress: PepsiCo, Procter & Gamble, CJ America, Inc., Syngenta Group, Bühler Group, Roquette, and Jiuding Weiye Group have already joined forces with us. They will share their scenario needs openly to drive the innovation in synthetic biology. Unparalleled Benefits for Startups: - Align with Industry Titans: Secure unparalleled business collaboration opportunities. - State-of-the-Art Facilities: Access to scaled experimental facilities for your research and development. - Supply Chain Mastery: Integrate into stable supply chains for seamless operations. - Investment Opportunities: Potential funding from venture capital firms, large enterprises, and Plug and Play. - Support Services: Receive comprehensive support for policy consultation, project application, and services for establishing roots in Beijing. Strategic Advantages for Big Corporations: - Enhance Visibility: Increase your brand's presence in cutting-edge technology sectors. - Innovative Synergy: Discover and connect with innovative enterprises to explore the next wave of disruptive innovation. - Cooperative Ecosystem: Forge new alliances and exchange ideas with other industry leaders. Ready to Accelerate Your Growth? Startups, scan the QR code below to register and secure your priority admission to the accelerator. Big corporations, reach out to Yutian Lu at yutian.lu@pnpchina.com to explore how you can drive innovation and growth together! Your journey to redefine the future of synthetic biology STARTS HERE. Join us in Pinggu for a sustainable and prosperous tomorrow. #Biotech #SyntheticBiology #Innovation #SustainableFuture

Caladan Bio—a startup developing a lower-cost benchtop bioreactor system designed to enhance data capture and increase experimentation throughput—has raised a $5m seed round led by Twelve Below. The round, supported by Lerer Hippeau, Collaborative Fund, Wireframe Ventures, Ritual Capital and Factorial Capital, will help the firm expand its team and its platform, says CEO Michael Kobida, who cofounded Caladan Bio last summer with college friend Rob Jauquet (CTO). “As the tools to edit cells become commonplace, the focus needs to shift towards optimizing scaleup of bio-made products,” says Kobida, who specializes in hardware, low-cost robotics and lab automation, while Jauquet focuses on software engineering, data and automation. “The vast majority of #synbio companies especially outside of the pharmaceutical industry, are struggling to achieve cost parity with incumbent products [made by petrochemicals or animals, for example]. “For these companies to optimize their scaling processes, they need to run hundreds if not thousands of experiments, which is incredibly costly. We’re focused on lowering the cost of those experiments and increasing the amount of data coming out of them so they can learn more using tools such as artificial intelligence and machine learning. The result is faster process optimization and a reduction in development timelines.” #bioreactors #syntheticbiology #SynBioBeta #precisionfermentation #bioeconomy #bioengineering AgFunder

I invite you to go through the latest newsletter from IKP!

A Training program on Innovation and Startup was organized for the students of PG Department of Biotechnology, Dwaraka Doss Goverdhan Doss Vaishnav College in association with IIC, at Golden Jubilee Biotech Park for Women Society on February 02, 2024.   Key takeaways from the training programme..   ·      Innovation and Startup at Golden Jubilee Biotech Park for Women Society ·      Technology and innovation are integral to the success of any startup or innovative organization. ·      The ability to think creatively and open-mindedly is essential ·      There is nothing more important than building and nurturing a talented team ·      The importance of flexibility and adaptability for individuals and organizations ·      It is important to embrace failure as a stepping stone towards success ·      A continuous learning process is essential to staying up-to-date on industry trends ·      It is essential to possess adaptability and resilience in order to succeed ·      Creating strong relationships with industry experts, mentors, and investors is essential for startup success   The students also got the opportunity to visit Adiuvo Diagnostics Pvt Ltd and MicroGo LLP, Designing Delivery Systems for Microbial Control unit. - PG Dept. of Biotech, DDGDVC #ddgdvc #dgvc #dgvcbiotech #biotechnology #lifesciences  #technosaviour #sustainability #sustainableproducts #innovation #startups #startupinnovation #incubationprogram

#Knowciicstartup Simbioen Labs and Scientific Services, a multifaceted startup based in Crescent Innovation & Incubation Council (CIIC), distinguishes itself through its innovative approach to pre-clinical drug discovery and biotechnical solutions in life sciences. Founded with the goal of revolutionizing traditional laboratory practices, Simbioen Labs provide specialized services tailored to the needs of researchers and industries across numerous scientific fields, including microbiology, bioinformatics, animal models, histopathology, and molecular biology. Simbioen Labs is deeply involved in research and development efforts to create technologies that push the boundaries of current scientific methods. By leveraging CIIC's technical mentorship and resource-sharing capabilities, Simbioen is focused on product development to tackle contemporary research challenges. With the support of CIIC, Simbioen received research grants from the Government of India and the Tamil Nadu State Government's innovation schemes, including Rs 3.75 lakhs from the Innovation Voucher Program (IVP), Rs 5 lakhs from Nidhi Prayas, and Rs 20 lakhs from the Startup India Seed Fund Scheme (SISFS). Notable products under development at Simbioen include superhydrophobic gloves, nanofertilizers, and ToxicChip. These initiatives aim to deliver sustainable solutions and have the potential to make a meaningful impact across various industries. Simbioen Labs | Startup India | Entrepreneurship Development and Innovation Institute #ciic #incubator #accelerator #startupenabler #startup #entrepreneurship #Innovation #students #entrpreneurs #crescent --- Parvez Alam M Nisha Mukund Ph.D NATARAJAN T.R Santhosh S